Neuroadaptations involved in amphetamine and cocaine addiction.
Department of Neuroscience, Finch University of Health Sciences, Chicago Medical School, North Chicago, IL, USA.
F J
FJ
White
P W
PW
Kalivas
D019969:Amphetamine-Related Disorders / Q000503:physiopathology*; D000662:Amphetamines / Q000494:pharmacology; D000818:Animals; D016739:Behavior, Addictive / Q000503:physiopathology*; D001921:Brain / Q000187:drug effects*; D002352:Carrier Proteins / Q000187:drug effects; D000697:Central Nervous System Stimulants / Q000494:pharmacology; D003042:Cocaine / Q000494:pharmacology; D019970:Cocaine-Related Disorders / Q000503:physiopathology*; D004298:Dopamine / Q000502:physiology; D050483:Dopamine Plasma Membrane Transport Proteins; D015536:Down-Regulation / Q000187:drug effects; D006801:Humans; D008562:Membrane Glycoproteins; D026901:Membrane Transport Proteins; D009294:Narcotics / Q000494:pharmacology; D009419:Nerve Tissue Proteins; D009431:Neural Conduction / Q000187:drug effects; D009434:Neural Pathways / Q000187:drug effects; D009714:Nucleus Accumbens / Q000187:drug effects; D017397:Prefrontal Cortex / Q000187:drug effects; D011954:Receptors, Dopamine / Q000187:drug effects; D017470:Receptors, Glutamate / Q000187:drug effects; D015398:Signal Transduction / Q000187:drug effects; D013997:Time Factors; D014158:Transcription, Genetic / Q000187:drug effects; D017557:Ventral Tegmental Area / Q000187:drug effects
D000662:Amphetamines; D002352:Carrier Proteins; D000697:Central Nervous System Stimulants; D050483:Dopamine Plasma Membrane Transport Proteins; D008562:Membrane Glycoproteins; D026901:Membrane Transport Proteins; D009294:Narcotics; D009419:Nerve Tissue Proteins; D011954:Receptors, Dopamine; D017470:Receptors, Glutamate; D003042:Cocaine; D004298:Dopamine